Active Biotech
0.05 SEK
-4.36 %
Less than 1K followers
ACTI
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Valuation
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Active Biotech
EV/S
Median 2019-2020
P/B
Median 2019-2025
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Share price (SEK) | 0.58 | 0.58 | 0.39 | 0.31 | 0.16 | 0.09 | 0.05 |
| Shares | 559.8 | 469.9 | 705.3 | 822.8 | 1,009.7 | 1,342.9 | 2,636.1 |
| Market cap | 326.8 | 274.5 | 275.5 | 254.8 | 165.1 | 115.9 | 121.3 |
| Enterprise value | 267.1 | 248.3 | 222.4 | 213.0 | 128.9 | 88.5 | - |
| EV/S | 31.8 | 37.1 | - | - | - | - | - |
| EV/EBITDA | neg. | neg. | neg. | neg. | neg. | neg. | - |
| EV/EBIT | neg. | neg. | neg. | neg. | neg. | neg. | - |
| P/E | neg. | neg. | neg. | neg. | neg. | neg. | neg. |
| P/B | 6.07 | 12.42 | 5.75 | 7.39 | 5.38 | 3.55 | 2.18 |
| P/S | 38.9 | 41.0 | - | - | - | - | - |
| Dividend yield | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % |
| Equity ratio | 80.3 % | 68.6 % | 84.3 % | 67.6 % | 69.8 % | 75.7 % | 79.2 % |
| Gearing ratio | - | - | - | - | - | - | - |